Neuroblastoma in the newborn. A study of the Italian Neuroblastoma Registry

European Journal of Cancer

Volumn 45, Issue 18, 2009, Pages 3220-3227

  Gigliotti, Anna Rita ^a   Di Cataldo, Andrea ^e   Sorrentino, Stefania ^a   Parodi, Stefano ^a   Rizzo, Antonino ^a   Buffa, Piero ^a   Granata, Claudio ^a   Sementa, Angela Rita ^a   Fagnani, Anna Maria ^b   Provenzi, Massimo ^c   Prete, Arcangelo ^d   D'Ippolito, Carmelita ^f   Clerico, Anna ^g   Castellano, Aurora ^h   Tonini, Gian Paolo ⁱ   Conte, Massimo ^a   Garaventa, Alberto ^a   De Bernardi, Bruno ^a  

^a G GASLINI INSTITUTE   (Italy)

^b FONDAZIONE IRCCS CA GRANDA OSPEDALE MAGGIORE POLICLINICO   (Italy)

^c Civic Hospital   (Italy)

^d UNIVERSITY OF BOLOGNA   (Italy)

^e UNIVERSITY OF CATANIA   (Italy)

^f UNIVERSITY OF BRESCIA   (Italy)

^g SAPIENZA UNIVERSITY OF ROME   (Italy)

^h BAMBINO GESÙ CHILDREN S HOSPITAL   (Italy)

ⁱ UNIVERSITY OF GENOA   (Italy)

Author keywords

Infant; MYCN gene; Neuroblastoma; Newborn; Prenatal diagnosis; Stage 4S disease

Indexed keywords

ANEUPLOIDY; ARTICLE; CANCER STAGING; CAUSE OF DEATH; CHROMOSOME 1P; CLINICAL FEATURE; COHORT ANALYSIS; DIPLOIDY; DISEASE COURSE; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; METASTASIS; NEUROBLASTOMA; NEWBORN; ONCOGENE MYC; OVERALL SURVIVAL; PRENATAL DIAGNOSIS; PRIORITY JOURNAL; TUMOR LOCALIZATION;

ADOLESCENT; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; BIOLOGICAL MARKERS; CARBOPLATIN; CHILD; CHILD, PRESCHOOL; COMBINED MODALITY THERAPY; CYCLOPHOSPHAMIDE; ETOPOSIDE; FEMALE; GENE AMPLIFICATION; HUMANS; INFANT; INFANT, NEWBORN; ITALY; MALE; NEOPLASM STAGING; NEUROBLASTOMA; PREGNANCY; PRENATAL DIAGNOSIS; REGISTRIES; SURVIVAL RATE; TREATMENT OUTCOME; VINCRISTINE;

EID: 70450267587     PISSN: 09598049     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejca.2009.08.020     Document Type: Article

References (30)

1. De Bernardi B., Pistoia V., Gambini C., and Granata C. Peripheral neuroblastic tumors. In: Sheaves R., Jenkins P.J., and Wass J.A. (Eds). Clinical endocrine oncology. 2nd ed. (2008), Blackwell Science, Oxford 360-369
2. De Bernardi B., Di Tullio M.T., Cordero di Montezemolo L., et al. Neuroblastoma under on year of age. Clinical aspects and management. In: Lampert F., Cordero di Montezemolo L., and Pession A. (Eds). Contributions to oncology -- cancer in the first year of life (1990), Karger, Basel 118-128
3. Potter E.L., and Craig J.M. Clinical manifestation of neuroblastoma in the fetus and infant. In: Gilbert-Barness E. (Ed). Potter's pathology of the fetus and infant. 2nd ed. (1975), Mosby Elsevier, Philadelphia 1659-1667
4. Acharya S., Jayabose S., Kogan S.J., et al. Prenatally diagnosed neuroblastoma. Cancer 80 2 (1997) 304-310
5. Tomà P., Lucigrai G., Marzoli A., and Lituania M. Prenatal diagnosis of metastatic adrenal neuroblastoma with sonography and MR imaging. Am J Roentgenol 162 5 (1994) 1183-1184
6. Granata C., Fagnani A.M., Gambini C., et al. Features and outcome of neuroblastoma detected before birth. J Pediatr Surg 35 1 (2000) 88-91
7. Jennings R.W., LaQuaglia M.P., Leong K., Hendren W.H., and Adzick N.S. Fetal neuroblastoma: prenatal diagnosis and natural history. J Pediatr Surg 28 9 (1993) 1168-1174
8. Kerbl R., Urban C.E., Lackner H., et al. Connatal localized neuroblastoma. Cancer 77 7 (1996) 1395-1401
9. Tsuchida Y., Ikeda H., Iehara T., Toyoda Y., Kawa K., and Fukuzawa M. Neonatal neuroblastoma: incidence and clinical outcome. Med Pediatr Oncol 40 6 (2003) 391-404
10. Michalowski M.B., Rubie H., Michon J., et al. Neonatal localized neuroblastoma: 52 cases treated from 1990 to 1999. Arch Pédiatr 11 7 (2004) 782-788
11. Lukens J.N. Neuroblastoma in the neonate. Semin Perinatol 23 4 (1999) 263-273
12. Luis A.L., Martinez L., Hernandez F., et al. Congenital neuroblastoma. Cir Pediatr 17 2 (2004) 89-92
13. Sauvat F., Sarnacki S., Brisse H., et al. Outcome of suprarenal localized masses diagnosed during the perinatal period. Cancer 94 9 (2002) 2474-2480
14. Nuchtern J.G. Perinatal neuroblastoma. Sem Ped Surg 15 1 (2006) 10-16
15. Conte M., Parodi S., De Bernardi B., et al. Neuroblastoma in adolescents: the Italian experience. Cancer 106 6 (2006) 1409-1417
16. Brodeur G.M., Pritchard J., Berthold F., et al. Revision of the international criteria for neuroblastoma diagnosis, staging and response to treatment. J Clin Oncol 11 8 (1993) 1466-1477
17. De Bernardi B., Gerrard M., Boni L., et al. Excellent outcome with reduced treatment for infants with disseminated neuroblastoma without MYCN gene amplification. J Clin Oncol 27 7 (2009) 1034-1040
18. Guglielmi M., De Bernardi B., Rizzo A., et al. Resection of primary tumor at diagnosis in stage IV-S neuroblastoma: does it affect the clinical course?. J Clin Oncol 14 5 (1996) 1537-1544
19. Moppett J., Haddadin I., and Foot A.B.M. Neonatal neuroblastoma. Arch Dis Child Fetal Neonatol 81 2 (1999) 134-137
20. Cecchetto G., Mosseri V., De Bernardi B., et al. Surgical risk factors in primary surgery for localized neuroblastoma: the LNESG1 study of the European International Society of Paediatric Oncology Neuroblastoma Group. J Clin Oncol 23 33 (2005) 8483-8489
21. Hero B., Simon T., Spitz R., et al. Localized infant neuroblastomas often show spontaneous regression: results of the prospective trials NB95-S and NB97. J Clin Oncol 26 9 (2008) 1504-1510
22. De Bernardi B., Pianca C., Boni L., et al. Disseminated neuroblastoma (stage IV and IV-S) in the first year of life. Outcome related to age and stage. Cancer 70 6 (1992) 1625-1633
23. Katzenstein H.M., Bowman L.C., Brodeur G.M., et al. Prognostic significance of age, MYCN oncogene amplification, tumor cell ploidy, and histology in 110 infants with stage D (S) neuroblastoma: the Pediatric Oncology Group experience - a Pediatric Oncology Group study. J Clin Oncol 16 6 (1998) 2007-2017
24. Look A.T., Hayes F.A., Nitschke R., Mc Williams N.B., and Green A.A. Cellular DNA content as a predictor of response to chemotherapy in infants with unresectable neuroblastoma. N Engl J Med 331 4 (1984) 231-235
25. Ladenstein R., Ambros I.M., Pötschger U., et al. Prognostic of DNA di-tetraploidy in neuroblastoma. Med Pediatr Oncol 36 1 (2001) 83-92
26. Minard V., Hartmann O., Peyroulet M.C., et al. Adverse outcome of infants with metastatic neuroblastoma, MYCN amplification and/or bone lesions: results of the French Society of Pediatric Oncology. Br J Cancer 83 8 (2000) 973-979
27. Schmidt M.L., Lukens J.N., Seeger R.C., et al. Biologic factors determine prognosis in infants with stage 4 neuroblastoma: a prospective children's cancer group study. J Clin Oncol 18 6 (2000) 1260-1268
28. Cañete A., Gerrard M., Rubie H., et al. Poor survival for infants with MYCN-amplified metastatic neuroblastoma despite intensified treatment: the International Society of Paediatric Oncology European Neuroblastoma Experience. J Clin Oncol 27 7 (2009) 1014-1019
29. Tonini G.P., Boni L., Pession A., et al. MYCN oncogene amplification in neuroblastoma is associated with worse prognosis, except in stage 4s: the Italian experience with 295 children. J Clin Oncol 15 1 (1997) 85-93
30. Schneiderman J., London W., Brodeur G.M., Castleberry R.P., Look A.T., and Cohn S.L. Clinical significance of MYCN amplification and ploidy in favourable-stage neuroblastoma: a report from the children's oncology group. J Clin Oncol 26 6 (2008) 913-918